1 tracked superinvestor hold ORIC PHARMACEUTICALS INC (ORIC), worth $56M combined, led by Andreas Halvorsen. Smart money is trimming ORIC as of the latest 13F filings.
Current price
$12.86
+19.4%
1Y
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another…
Market cap
$980M
P/E
-6.65
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$21
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$56M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
-1
0 buying · 1 selling
Smart money is net reducing ORIC: 1 funds trimmed versus 0 adding.
ORIC PHARMACEUTICALS INC (ORIC) is held by 1 tracked funds worth $56M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 0 added and 1 trimmed, a net reduction.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 0.2% | $56M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own ORIC?
1 tracked funds hold ORIC PHARMACEUTICALS INC (ORIC), the largest being Andreas Halvorsen (Viking Global Investors) at 0.2% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling ORIC?
In the most recent 13F quarter, 0 tracked funds added or opened ORIC and 1 trimmed it.
How much ORIC do tracked funds hold?
Combined disclosed long exposure to ORIC across tracked superinvestors is $56M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.